CALA Relative Valuation - Calithera Biosciences Inc - Alpha Spread
C

Calithera Biosciences Inc
OTC:CALA

Watchlist Manager
Calithera Biosciences Inc
OTC:CALA
Watchlist
Price: 0.02 USD Market Closed
Market Cap: 97.5k USD
Have any thoughts about
Calithera Biosciences Inc?
Write Note

Relative Value

There is not enough data to reliably calculate the relative value of CALA.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CALA Relative Value
Base Case
Not Available
C
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.8
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
-0
Industry
23.7
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0
Industry
22.3
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0
Industry
24.8
vs History
vs Industry
Median 3Y
0.1
Median 5Y
0
Industry
2.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.8
vs History
vs Industry
Median 3Y
0.6
Median 5Y
0.6
Industry
4.8
vs History
vs Industry
Median 3Y
0.6
Median 5Y
0.6
Industry
4.5
vs History
vs Industry
Median 3Y
0.6
Median 5Y
0.9
Industry
6.4
vs History
vs Industry
Median 3Y
0.6
Median 5Y
0.9
Industry
4.4
vs History
vs Industry
Median 3Y
-9.8
Median 5Y
-13.1
Industry
4.8

Multiples Across Competitors

CALA Competitors Multiples
Calithera Biosciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Calithera Biosciences Inc
OTC:CALA
1m USD 0 -0.1 0.6 0.6
US
Abbvie Inc
NYSE:ABBV
341.7B USD 6.2 64.5 15.8 24.1
US
Amgen Inc
NASDAQ:AMGN
181.2B USD 5.9 57.9 20.2 36.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
126.5B USD 9.4 29.3 25.7 28.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120B USD 11.6 -245 26 27.3
US
Epizyme Inc
F:EPE
94.1B EUR 1 981.8 -505.7 -550.7 -536
US
Gilead Sciences Inc
NASDAQ:GILD
103.6B USD 3.7 98.4 9.4 11.9
AU
CSL Ltd
ASX:CSL
141.9B AUD 6.5 36.6 22.4 27.9
US
Seagen Inc
F:SGT
39.3B EUR 19.1 -58.5 -63 -56.9
US
Palatin Technologies Inc
LSE:0KF3
38.5B USD 6 513.5 -1 169.6 -1 185.3 -1 173.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
35.1B USD 15 -480.9 211.7 325.8
P/E Multiple
Earnings Growth
US
C
Calithera Biosciences Inc
OTC:CALA
Average P/E: 57.3
Negative Multiple: -0.1
N/A
US
Abbvie Inc
NYSE:ABBV
64.5
406%
US
Amgen Inc
NASDAQ:AMGN
57.9
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.3
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -245
38%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
98.4
71%
AU
CSL Ltd
ASX:CSL
36.6
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.5 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 169.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -480.9 N/A

See Also

Discover More
Back to Top